International Journal of Cancer Medicine
Home
The International Journal of Cancer Medicine, with a DOI prefix of 10.46619 and an Impact Factor of 4.2, is a peer-reviewed open access journal that covers all aspects of cancer research, particularly novel concepts and theories, new techniques, therapeutic agents, and alternative approaches for early detection and intervention of cancer.
The journal's objective is to advance the field of cancer or oncology by publishing articles focused on disease management, prevention, early diagnosis methods, specific classes of therapeutic agents, clinical trial results, emerging interventional techniques, supportive care, and rehabilitation /reconstruction. The journal's rigorous single-blinded peer-review process ensures the rapid publication of high-quality cancer research results.
Currently, all students and emeritus professors can submit and publish their manuscripts at a discounted rate. Additionally, the published articles are available to online readers free of charge.
Authors Funded by the NIH: This journal automatically deposits papers to PubMed Central after publication of an issue (NIHMS, http://nihms.nih.gov/).
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC https://www.coronavirus.gov
Get the latest research https://www.who.int/emergencies/diseases/novel-coronavirus-2019
64%
45
10
120
Recently Published Articles
Review Article | Volume 7, Issue 1 | Open Access
Emerging Indications for Neoadjuvant Systemic Therapies in Cutaneous Malignancies
Domingos Lins Junior, Beatriz Mendes Awni Cidale, Ana Zelia Leal Pereira, Jacqueline Nunes de Menezes, Eduardo Bertolli, Francisco Aparecido Belfort, and Rodrigo Ramella Munhoz
Research Article | Volume 7, Issue 1 | Open Access
What could be Improved at Melanoma Patients’ Welfare Death? End of Life Perception of Caregivers
Fernanda Cardoso Parreiras, Ana Paula Drummond-Lage, Marina Patrus Ananias de Souza Brandao, Laura Nogueira Silva, Lara Salvador Geo, Brenda Bhering Andrade, Andreia Cristina de Melo and Alberto Julius Alves Wainstein
Research Article | Volume 7, Issue 1 | Open Access
Mutational Spectra of Epithelial Mesenchymal Transition Markers-SOX4, EpCAM, CK19 and their Impact of Methylene Tetrahydrofolate Reductase C677T Gene Polymorphism Associated Risk Factor Modified by BRCA1/2 and TGF-βR1 Genes
Ajit Kumar Saxena, Meenakshi Tiwari, Pritanjali Singh, Veena Singh and Manoj Kumar
Research Article | Volume 7, Issue 1 | Open Access
Cancer Patients Admitted to the Emergency Department
Valéry Refeno, Rova Malala Fandresena Randrianarisoa, Hery Randrianirina, Ernestine Faly, Giannie Rasamimanana, Andriambelo Tovohery Rajaonera and Florine Rafaramino
Review Article | Special Issue | Open Access
Targeted and Immunotherapeutic Approaches in Breast Cancers
Rasit Dinc
Research Article | Special Issue | Open Access
Complement Components C3 and C7 as Potential Therapeutic and Prognostic Targets for Adrenocortical Carcinoma
Yongli Situ, Xiaoli Jiang, Ziqing Huang, Juying Zhang, Lingling Lu, Quanyan Liang, Li Deng, Qinying Xu and Zheng Shao
Clinical Research | Special Issue | Open Access
Regenerating Family Member 4 Expression was a Potential Marker for Carcinogenesis, Aggressiveness and Prognosis of Gastric Cancer
Cong-yu Zhang, Li Zhang, Hong-zhi Sun, Min-wen Ha, Zheng-guo Cui and Hua-chuan Zheng
Clinical Research | Special Issue | Open Access
Nivolumab Hepatocellular Carcinoma
Timothy Schieber, Matthew Arango, Kathryn Herr, Missy Sweeney, Eric Mclaughlin, Anne Noonan, and Daniel Kendzierski
Clinical Research | Special Issue | Open Access
Evaluation of Axillary Lymph Node Recurrence and Adverse Effects of Sentinel Lymph Node Biopsy with Single Technique Methylene Blue 1%: A Case Series in Indonesia
Dedy Hermansyah and Muhammad Al Anas
Clinical Research | Volume 6, Issue 3 | Open Access
Hematopoietic Stem Cell Transplantation Experience: A Retrospective Analysis from Largest Center of India’s Largest State
Sandeep kumar Jasuja, Mukesh Kumar, Aditi Mittal, Krutika Goyal, Sajna Choudhary, Ashish Dayma, Linu Hooda and Jaiprakash Yadav
Aims & Scope
The primary objective of the International Journal of Cancer Medicine is to enhance and disseminate knowledge and global health outcomes by promptly publishing top-quality research articles, reviews, and case reports conveying important practice messages to the scientific community. The journal welcomes all types of articles covering various areas of Cancer Biology, Clinical Cancer Research, Cancer Prevention, and related fields, with the belief that the best research should be rapidly published and made widely accessible.
The International Journal of Cancer Medicine will accept submissions from all oncological specialties, including, but not limited to, the following areas:
- Cancer
- Cancer Diseases
- Endocrine disorders
- Breast cancer
- Blood diseases
- Cancer statistics
- Cancer diagnosis
- Carcinogenesis - etiology, mechanisms
- Molecular biology
- Recent developments in tumor therapy
- General diagnosis
- Laboratory diagnosis
- Diagnostic and experimental pathology
- Oncologic surgery
- Epidemiology
- Treatment strategies
- Evaluations of current therapies
- Models for integrating complementary and conventional treatment in clinical practice
- Interventions from alternative and traditional medicine
- Implementing quality-of-life assessment and counseling in the clinical setting
- Cancer rehabilitation during and following cancer treatments
- Potential interactions of cancer chemotherapy drugs with frequently used dietary supplements
- Implementing integrative cancer care strategies into oncology practice
- Relevant molecular mechanisms and biology behind integrative approaches
- Impact of timing of chemotherapy administration on toxicity
- Response, and outcome by leading oncologists
- Researchers, and health-care professionals
- Cancer Medicine and Metastasis